Found: 7
Select item for more details and to access through your institution.
Cancer of unknown primary derived from regressed breast cancer.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Highlights of Translational and Molecular Research Presented at the European Society for Medical Oncology Annual Meeting 2023.
- Published in:
- Oncology Research & Treatment, 2024, v. 47, n. 4, p. 149, doi. 10.1159/000537940
- By:
- Publication type:
- Article
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary.
- Published in:
- Clinical Chemistry, 2024, v. 70, n. 1, p. 297, doi. 10.1093/clinchem/hvad180
- By:
- Publication type:
- Article
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42400-5
- By:
- Publication type:
- Article
CUP-Syndrom – die neue ESMO-Leitlinie.
- Published in:
- Die Radiologie, 2023, v. 63, n. 5, p. 329, doi. 10.1007/s00117-023-01126-7
- By:
- Publication type:
- Article
Cancer of unknown primary (CUP) – lokal begrenzt, oligometastatisch und im Kopf-Hals-Bereich.
- Published in:
- Die Radiologie, 2023, v. 63, n. 5, p. 358, doi. 10.1007/s00117-023-01133-8
- By:
- Publication type:
- Article
Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primary.
- Published in:
- Genes, Chromosomes & Cancer, 2022, v. 61, n. 9, p. 551, doi. 10.1002/gcc.23047
- By:
- Publication type:
- Article